ATOS (STOCKS)
Atossa Therapeutics, Inc. Common Stock
$4.190000
-0.630000 (-13.07%)
Prev close: $4.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Steven C. Quay
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $36.08M
- Employees
- 13
- P/E (TTM)
- -1.37
- P/B (TTM)
- 0.83
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.05 | $-1.02 | -0.0299 | -2.93% |
|
Jun 2025 (Q2)
|
$-1.05 | $-0.88 | -0.1702 | -19.35% |
|
Mar 2025 (Q1)
|
$-0.05 | $-0.06 | +0.0078 | +13.49% |
|
Dec 2024 (Q4)
|
$-0.05 | $-0.06 | +0.0146 | +22.60% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $32.86M |
| Research and Development | $18.43M |
| Other Operating Expenses | $14.42M |
| Operating Income/Loss | -$32.86M |
| Income/Loss From Continuing Operations After Tax | -$30.18M |
| Income/Loss From Continuing Operations Before Tax | -$30.18M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$30.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$30.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$30.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.24 |
| Diluted Earnings Per Share | -$0.24 |
| Basic Average Shares | 258,592,122 |
| Diluted Average Shares | 258,592,122 |
| Assets | $58.01M |
| Current Assets | $55.68M |
| Prepaid Expenses | $580.00K |
| Other Current Assets | $55.10M |
| Noncurrent Assets | $2.33M |
| Liabilities | $8.23M |
| Current Liabilities | $8.23M |
| Accounts Payable | $3.54M |
| Wages | $1.13M |
| Other Current Liabilities | $3.56M |
| Noncurrent Liabilities | $0.00 |
| Equity | $49.79M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $49.79M |
| Liabilities And Equity | $58.01M |
| Net Cash Flow From Operating Activities | -$26.27M |
| Net Cash Flow From Operating Activities, Continuing | -$26.27M |
| Net Cash Flow From Investing Activities | -$16.00K |
| Net Cash Flow From Investing Activities, Continuing | -$16.00K |
| Net Cash Flow From Financing Activities | $22.61M |
| Net Cash Flow From Financing Activities, Continuing | $22.61M |
| Net Cash Flow | -$3.68M |
| Net Cash Flow, Continuing | -$3.68M |
| Comprehensive Income/Loss | -$30.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.18M |
| Other Comprehensive Income/Loss | $0.00 |